However, it must be stressed that the presence of IDH1 mutation now precludes the formal pathological diagnosis of glioblastoma, as it is now genetically defined as “IDH-wildtype” in the most recent edition of the WHO Classification of CNS Tumors (24). The gene discussed is IDH1; the disease is central nervous system neoplasm.